Latest posts in

Articles

Navigating the uncharted terrain of the Consolidated Appropriations Act: guidance for employer health plans
Navigating the uncharted terrain of the Consolidated Appropriations Act: guidance for employer health plans

Read
In Support of Common Sense PBM Reform: Capital Rx Testimony Highlights
In Support of Common Sense PBM Reform: Capital Rx Testimony Highlights

Highlights of Capital Rx SVP Josh Golden's 9/28 testimony on PBM reform before Kentucky State Sen. Alvarado, et al.

Read
It’s Okay to Have Zero Trust During Cybersecurity Awareness Month
It’s Okay to Have Zero Trust During Cybersecurity Awareness Month

Capital Rx's cybersecurity team discusses Zero Trust, Digital Trust, and some tips/best practices for Cybersecurity Month...

Read
PMPM - Is It the Best Way to Measure or Track Anything?
PMPM - Is It the Best Way to Measure or Track Anything?

PMPM is widely used and has utility, but it is not perfect and can lead to confusion or even frustration due to several issues.

Read
What Really Makes a Pharmacy Benefit Administration (PBA) Solution Different?
What Really Makes a Pharmacy Benefit Administration (PBA) Solution Different?

What is a pharmacy benefit administrator (PBA), and what's missing from traditional PBA solutions?

Read
What Is the Role of a Pharmacy Benefits Manager (PBM)?
What Is the Role of a Pharmacy Benefits Manager (PBM)?

Pharmacy benefit managers, commonly known as PBMs, handle one of the most important and continually debated aspects of Americans’ lives: access to prescription drugs. Read about PBMs in our latest blog.

Read
A Message From Our Founder: Announcing Our Series C Funding Round
A Message From Our Founder: Announcing Our Series C Funding Round

Read a special message from our Founder as he announces our Series C Funding Round.

Read
As Feds Probe Pharma’s Middlemen, Capital Rx Raises $106 Million For Software-Driven Fix
As Feds Probe Pharma’s Middlemen, Capital Rx Raises $106 Million For Software-Driven Fix

Thank you to Forbes’ Katie Jennings for expertly summarizing the challenges consumers face as a result of rising drug prices, as well as how Capital Rx’s $106M Series C funding will help accelerate the company's mission.

Read